Minireviews
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Sep 27, 2021; 13(9): 1098-1106
Published online Sep 27, 2021. doi: 10.4254/wjh.v13.i9.1098
Liver transplantation for benign liver tumors
Ana Ostojic, Anna Mrzljak, Danko Mikulic
Ana Ostojic, Anna Mrzljak, Department of Gastroenterology and Hepatology, University Hospital Center Zagreb, Zagreb 10000, Croatia
Danko Mikulic, Department of Surgery, University Hospital Merkur, Zagreb 10000, Croatia
Author contributions: Ostojic A, Mrzljak A and Mikulic D made contributions to the conception and design of the study, collection of data and in drafting and revising the manuscript; all authors read and approved the final manuscript.
Conflict-of-interest statement: None of the authors have any conflict of interest to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Danko Mikulic, FEBS, MD, PhD, Surgeon, Department of Surgery, University Hospital Merkur, Zajceva 19, Zagreb 10000, Croatia. danko.mikulic@zg.t-com.hr
Received: February 24, 2021
Peer-review started: February 24, 2021
First decision: May 3, 2021
Revised: May 12, 2021
Accepted: July 21, 2021
Article in press: July 21, 2021
Published online: September 27, 2021
Processing time: 209 Days and 15.4 Hours
Core Tip

Core Tip: Liver transplantation (LT) is rarely performed for benign liver tumors. However, LT is a valid and efficient treatment option in selected patients with life-threatening complications or when surgical resection is impossible. The indications for LT for these lesions are still not well defined. This report focuses on the indications for LT and long-term LT outcomes in patients who underwent transplantation for benign liver tumors.